about
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also con...
Read More
17.17
0.67
(4.06%)
35,654
XNAS Volume
XNAS 29 May, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Polyrizon Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..